{"id":74368,"date":"2026-04-16T12:43:31","date_gmt":"2026-04-16T17:43:31","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/topics\/breast-cancer-screening-canada\/elevated-and-high-risk\/abnormal-call-rate\/"},"modified":"2026-07-06T07:42:51","modified_gmt":"2026-07-06T12:42:51","slug":"abnormal-call-rate","status":"publish","type":"topics","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-cancer-screening-canada\/elevated-and-high-risk\/abnormal-call-rate\/","title":{"rendered":"Taux de rappel pour anomalie"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":95,"featured_media":0,"parent":74354,"menu_order":4,"template":"","topics_tags":[],"type-of-care":[],"cancer-continuum":[],"cancer-system-measurement":[],"dbt-cancer-site":[],"dbt-risk-factors":[],"dbt-population-characteristics":[],"class_list":["post-74368","topics","type-topics","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Partnership Against Cancer<\/title>\n<meta name=\"description\" content=\"The abnormal call rate (ACR) \u2014 the percentage of mammograms identified as abnormal \u2014 is a key quality indicator of breast screening programs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-cancer-screening-canada\/elevated-and-high-risk\/abnormal-call-rate\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Taux de rappel pour anomalie - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"The abnormal call rate (ACR) \u2014 the percentage of mammograms identified as abnormal \u2014 is a key quality indicator of breast screening programs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-cancer-screening-canada\/elevated-and-high-risk\/abnormal-call-rate\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-06T12:42:51+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-cancer-screening-canada\\\/elevated-and-high-risk\\\/abnormal-call-rate\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-cancer-screening-canada\\\/elevated-and-high-risk\\\/abnormal-call-rate\\\/\",\"name\":\"Taux de rappel pour anomalie - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"datePublished\":\"2026-04-16T17:43:31+00:00\",\"dateModified\":\"2026-07-06T12:42:51+00:00\",\"description\":\"The abnormal call rate (ACR) \u2014 the percentage of mammograms identified as abnormal \u2014 is a key quality indicator of breast screening programs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-cancer-screening-canada\\\/elevated-and-high-risk\\\/abnormal-call-rate\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-cancer-screening-canada\\\/elevated-and-high-risk\\\/abnormal-call-rate\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-cancer-screening-canada\\\/elevated-and-high-risk\\\/abnormal-call-rate\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Topics\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/topics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"D\u00e9pistage du cancer du sein au Canada, 2026\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-cancer-screening-canada\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Risque accru et risque \u00e9lev\u00e9\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-cancer-screening-canada\\\/elevated-and-high-risk\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Taux de rappel pour anomalie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","description":"The abnormal call rate (ACR) \u2014 the percentage of mammograms identified as abnormal \u2014 is a key quality indicator of breast screening programs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-cancer-screening-canada\/elevated-and-high-risk\/abnormal-call-rate\/","og_locale":"fr_FR","og_type":"article","og_title":"Taux de rappel pour anomalie - Canadian Partnership Against Cancer","og_description":"The abnormal call rate (ACR) \u2014 the percentage of mammograms identified as abnormal \u2014 is a key quality indicator of breast screening programs.","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-cancer-screening-canada\/elevated-and-high-risk\/abnormal-call-rate\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2026-07-06T12:42:51+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-cancer-screening-canada\/elevated-and-high-risk\/abnormal-call-rate\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-cancer-screening-canada\/elevated-and-high-risk\/abnormal-call-rate\/","name":"Taux de rappel pour anomalie - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"datePublished":"2026-04-16T17:43:31+00:00","dateModified":"2026-07-06T12:42:51+00:00","description":"The abnormal call rate (ACR) \u2014 the percentage of mammograms identified as abnormal \u2014 is a key quality indicator of breast screening programs.","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-cancer-screening-canada\/elevated-and-high-risk\/abnormal-call-rate\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-cancer-screening-canada\/elevated-and-high-risk\/abnormal-call-rate\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-cancer-screening-canada\/elevated-and-high-risk\/abnormal-call-rate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Topics","item":"https:\/\/www.partnershipagainstcancer.ca\/topics\/"},{"@type":"ListItem","position":2,"name":"D\u00e9pistage du cancer du sein au Canada, 2026","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-cancer-screening-canada\/"},{"@type":"ListItem","position":3,"name":"Risque accru et risque \u00e9lev\u00e9","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-cancer-screening-canada\/elevated-and-high-risk\/"},{"@type":"ListItem","position":4,"name":"Taux de rappel pour anomalie"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/74368","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/topics"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/95"}],"up":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/74354"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=74368"}],"wp:term":[{"taxonomy":"topics_tags","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics_tags?post=74368"},{"taxonomy":"type-of-care","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/type-of-care?post=74368"},{"taxonomy":"cancer-continuum","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-continuum?post=74368"},{"taxonomy":"cancer-system-measurement","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-system-measurement?post=74368"},{"taxonomy":"dbt-cancer-site","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-cancer-site?post=74368"},{"taxonomy":"dbt-risk-factors","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-risk-factors?post=74368"},{"taxonomy":"dbt-population-characteristics","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-population-characteristics?post=74368"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}